Evotec AG has deepened its commercial ties with Sanofi SA with an agreement to develop a beta cell replacement therapy for people with diabetes. The German company is already working with Harvard University on beta cell technology. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
